Comments
Dr Reddy’s Laboratories has announced expansion of its manufacturing facility in Mirfield, UK, which deals with Custom Pharmaceutical Services (CPS) business. The expansion will be in the areas of activated mPEG manufacturing and in the development and manufacture of NCE (New Chemical Entities) APIs for use in pre-clinical through to commercial development.
The move will put Dr Reddy's at the forefront of activated mPEG manufacturing and will enable manufacture of its PEGtech range at commercial quantities, a company press release stated today.
Commenting on the development, R. Ananthanarayanan, President-Pharmaceutical Services and Active Ingredients business, said: “This expansion builds on our commitment to expand operations in the UK and provide a superior network of cGMP manufacturing to support our global customer base”.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.